Arrestin-C Inhibitors

The chemical class known as Arrestin-C inhibitors encompasses molecules that interact with G protein-coupled receptor (GPCR) signaling pathways. Arrestin-C is involved in the regulation of these pathways by facilitating the desensitization, internalization, and trafficking of GPCRs. Consequently, inhibitors in this class do not bind directly to Arrestin-C but influence its activity by modulating the receptors or signaling mechanisms it regulates.

Arrestin-C functions are modulated indirectly through the inhibition of associated GPCRs, altering receptor phosphorylation states, or by targeting downstream signaling molecules such as kinases in the MAPK pathway. The chemical inhibitors listed may alter the cellular location of Arrestin-C, its state of activation, or the outcome of its engagement with GPCRs. These small molecules range from receptor antagonists, such as propranolol, to kinase inhibitors, like PD 98059, each influencing the complex signaling networks Arrestin-C is part of. While these inhibitors do not interact with Arrestin-C directly, their effects on GPCR signaling pathways can effectively modulate the functional outcomes of Arrestin-C activity within the cell.